During this reporting period the Laboratory of Genetics and Physiology has initiated a program to study the role of cytokine-STAT5 signaling in the epigenetic programming of cells. As a test system we have analyzed mouse embryonic fibroblasts in the presence and absence of STAT5. We established the histone modification code for wild type cells as a basis for comparison of these marks in cells that lack one or both STAT5 proteins. Upon completion of the test program, we will expand into other cell types, whose biology greatly depends on cytokine signaling, such as mammary and hematopoietic cells.

Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2009
Total Cost
$989,550
Indirect Cost
City
State
Country
Zip Code
Yoo, Kyung Hyun; Oh, Sumin; Kang, Keunsoo et al. (2015) Loss of EZH2 results in precocious mammary gland development and activation of STAT5-dependent genes. Nucleic Acids Res :
Bae, Woo Kyun; Kang, Keunsoo; Yu, Ji Hoon et al. (2015) The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration. FASEB J 29:1653-62
Bae, Woo Kyun; Yoo, Kyung Hyun; Lee, Ji Shin et al. (2015) The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Mol Carcinog 54:1172-80
Bae, Woo Kyun; Hennighausen, Lothar (2014) Canonical and non-canonical roles of the histone methyltransferase EZH2 in mammary development and cancer. Mol Cell Endocrinol 382:593-597
Zhu, Bing-Mei; Kang, Keunsoo; Yu, Ji Hoon et al. (2012) Genome-wide analyses reveal the extent of opportunistic STAT5 binding that does not yield transcriptional activation of neighboring genes. Nucleic Acids Res 40:4461-72
Yoo, Kyung Hyun; Hennighausen, Lothar (2012) EZH2 methyltransferase and H3K27 methylation in breast cancer. Int J Biol Sci 8:59-65